Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
28.54
-0.74 (-2.53%)
At close: Mar 6, 2026

SHA:688319 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20.7617.5626.58107.96
Depreciation & Amortization
31.6530.8125.323.04
Other Amortization
4.353.153.431.64
Loss (Gain) From Sale of Assets
0.030.150.150.01
Loss (Gain) From Sale of Investments
-0.86-1.04-3.7-3.76
Provision & Write-off of Bad Debts
10.191.7212.189
Other Operating Activities
6.675.669.130.12
Change in Accounts Receivable
-83.630.98-151.92-147.16
Change in Inventory
-13.571.68-7.96-27.28
Change in Accounts Payable
19.06-12.364.4681.2
Operating Cash Flow
-9.7344-24.5539.96
Operating Cash Flow Growth
---89.49%
Capital Expenditures
-207.32-169.88-200.69-69.71
Sale of Property, Plant & Equipment
0.03--0.01
Investment in Securities
-17.590140-190
Other Investing Activities
0.861.043.73.76
Investing Cash Flow
-223.93-78.84-56.99-255.94
Long-Term Debt Issued
206.82208.25129.9935
Total Debt Issued
206.82208.25129.9935
Long-Term Debt Repaid
-78.85-100.06-40-27.34
Total Debt Repaid
-78.85-100.06-40-27.34
Net Debt Issued (Repaid)
127.97108.1989.997.66
Issuance of Common Stock
-10.3817.65371.81
Repurchase of Common Stock
-2.39---
Common Dividends Paid
-29.68-5.99-4.25-1.03
Other Financing Activities
-16.68--9.64
Financing Cash Flow
95.91129.27103.38368.79
Net Cash Flow
-137.7694.4221.84152.82
Free Cash Flow
-217.05-125.88-225.24-29.75
Free Cash Flow Margin
-36.86%-25.37%-41.14%-6.11%
Free Cash Flow Per Share
-0.54-0.31-0.56-0.08
Cash Income Tax Paid
25.5934.193516.56
Levered Free Cash Flow
-198.15-140.57-198.44-67.11
Unlevered Free Cash Flow
-189.11-136.09-195.27-66.34
Change in Working Capital
-82.52-14-97.61-98.05
Source: S&P Global Market Intelligence. Standard template. Financial Sources.